Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06502171
Title Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas (NF113)
Acronym NF113
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Girish Dhall, MD
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.